NMT Medical, Inc.
NMT Medical company develops implantable devices that treat defects in the walls of the heart's chambers. Its CardioSEAL and STARFlex implants close up holes in the heart, a condition suffered primarily by children.NMT Medical company markets CardioSEAL and STARFlex in the US, Canada, and Europe. A third device, BioSTAR, is a bioabsorbable implant that also corrects heart defects; it has been approved in Canada and Europe. NMT Medical acquired the exclusive rights to CardioSEAL from InnerVentions, a licensee of Children's Hospital Boston.
Contact Details
Executives
Chairman, President, and CEO
Richard E. (Rick) Davis
Director Marketing
Ron Seyffert